Symbol
| GPR17
| contributors: mct/npt - updated : 19-12-2013
|
HGNC name
| G protein-coupled receptor 17
|
HGNC id
| 4471
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in demyelinating lesions in the CNS  | constitutional
|  
|  
| --over
|  
|
in multiple sclerosis plaques  | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| |
|
System | Type | Disorder | Pubmed |
immunology | autoimmune | multiple sclerosis |  |
inhibiting GPR17 emerges as therapeutic strategy to relieve the oligodendrocyte maturation block and promote myelin repair in MS | neurology | neurodegenerative | |  |
may serve as a potential therapeutic target for CNS myelin repair | neurology | acquired | |  |
target for neurorepair and are particularly relevant to setting up new therapies for traumatic brain injury (TBI) patients |
| | |
| Gpr17 knockout mice showed early onset of oligodendrocyte myelination  |